Thus, this group introduced a promising role of aspirin, which could directly acetylate cGAS to inhibit cGAS activation, as a therapeutic strategy in treating autoimmune diseases, such as Aicardi–Goutieres syndrome (AGS) [66,78,79]. Here, CGAS is linked to Aicardi-Goutieres syndrome.